Palatin Technologies Inc. (PTN)

[mikedeatworld]

Bremelanotide, is far superior, compared to Addyi. Now, we have to hope they can hold on and not have to do a reverse split, and filter through the "Addyi isn't selling" noise, to get a good deal.

In the past, they have had offers for 250M for Bremelanotide partnership with King Pharmaceuticals. However, that was way before there were regulatory hurdles cleared by another company (Sprout). After this partnership news, in 2004-2006, the stock was trading at roughly, $3 (later there was a 1:10 R/S).

http://finance.yahoo.com/q/hp?s=PTN&a=00&b=15&c=2006&d=11&e=24&f=2006&g=d

http://web.archive.org/web/20060215224758/http://www.palatin.com/strategicalliances/overview.asp

If they can get a partnership, for 500M this could, fly to $4-5 / share easily. Anything above that, would be....well...gravy, with stuffing, turkey, and mashed potatoes.